FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly cardiology and endocrinology; it allows thrombocyte functions optimisation in metabolic syndrome patients. The method includes combination of low-calorie diet, calculated by special formula, and administration of drugs: 10 mg felodipine daily, 6.21 mg spirapryle every morning.
EFFECT: allows normalisation of thrombocyte functions, namely, thrombocyte receptivity to aggregation inducers, to the 12th week of treatment.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT METHOD FOR PRIMARY HEMOSTASIA DISORDERS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342137C2 |
| METHOD FOR THROMBOCYTE FUNCTION RECOVERY IN METABOLIC SYNDROME CONDITIONS | 2007 |
|
RU2342135C2 |
| METHOD OF FUNCTIONAL ABILITY NORMALISATION | 2007 |
|
RU2342128C1 |
| METHOD OF NORMALISATION OF INTRAVASCULAR ACTIVITY OF THROMBOCYTES AT METABOLIC SYNDROME | 2007 |
|
RU2338534C1 |
| METHOD OF THROMBOCYTE ACTIVITY OPTIMISATION ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2337686C1 |
| METHOD FOR THROMBOCYTE DISORDERS CORRECTION IN METABOLIC SYNDROME | 2007 |
|
RU2342136C2 |
| METHOD OF DECREASE OF BLOOD PLATES ACTIVITY AT METHABOLIC SYNDROME | 2007 |
|
RU2337683C1 |
| TREATMENT METHOD FOR PLATELET DYSFUNCTION IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342134C1 |
| METHOD OF LEVELLING OF DYSFUNCTIONS OF THROMBOCYTES IN CONDITIONS OF METABOLIC SYNDROME | 2007 |
|
RU2343916C1 |
| METHOD FOR NORMALIZING THROMBOCYTIC DISORDERS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268046C1 |
